SAN FRANCISCO – Prescription drug distributor McKesson Corp. is buying Canadian pharmacy operator Rexall Health from Katz Group for $2.2 billion, strengthening McKesson’s Canadian pharmaceutical supply chain.
The deal would be worth about $1.9 billion after tax benefits. It is expected to close late this year.
San Francisco-based McKesson will acquire about 470 of Rexall’s retail pharmacies, bolstering its Canadian operations and bringing the number of employees at its Canadian unit to 13,000.
Local journalism is essential.
Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.
Subscribe to the Coronavirus newsletter
Get the day’s latest Coronavirus news delivered to your inbox by subscribing to our newsletter.